GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Karo Pharma AB (OTCPK:KARBF) » Definitions » E10

Karo Pharma AB (Karo Pharma AB) E10 : $0.00 (As of Jun. 2022)


View and export this data going back to . Start your Free Trial

What is Karo Pharma AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Karo Pharma AB's adjusted earnings per share data for the three months ended in Jun. 2022 was $0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.00 for the trailing ten years ended in Jun. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-13), Karo Pharma AB's current stock price is $5.25. Karo Pharma AB's E10 for the quarter that ended in Jun. 2022 was $0.00. Karo Pharma AB's Shiller PE Ratio of today is .


Karo Pharma AB E10 Historical Data

The historical data trend for Karo Pharma AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karo Pharma AB E10 Chart

Karo Pharma AB Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.99 -0.25 -0.16 -0.09 -0.01

Karo Pharma AB Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Jun22
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.04 -0.02 -0.01 -

Competitive Comparison of Karo Pharma AB's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Karo Pharma AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Karo Pharma AB's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Karo Pharma AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Karo Pharma AB's Shiller PE Ratio falls into.



Karo Pharma AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Karo Pharma AB's adjusted earnings per share data for the three months ended in Jun. 2022 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2022 (Change)*Current CPI (Jun. 2022)
=0/118.3836*118.3836
=0.000

Current CPI (Jun. 2022) = 118.3836.

Karo Pharma AB Quarterly Data

per share eps CPI Adj_EPS
201206 -0.102 100.352 -0.120
201209 -0.055 100.467 -0.065
201212 -0.041 100.403 -0.048
201303 -0.040 100.416 -0.047
201306 -0.059 100.206 -0.070
201309 0.020 100.544 0.024
201312 -0.012 100.541 -0.014
201403 -0.040 99.788 -0.047
201406 -0.043 100.432 -0.051
201409 -0.027 100.161 -0.032
201412 -0.055 100.225 -0.065
201503 -0.035 99.950 -0.041
201506 -0.046 99.995 -0.054
201509 -0.028 100.228 -0.033
201512 -0.062 100.276 -0.073
201603 0.005 100.751 0.006
201606 -0.004 101.019 -0.005
201609 0.006 101.138 0.007
201612 0.111 102.022 0.129
201703 0.025 102.022 0.029
201706 0.017 102.752 0.020
201709 0.019 103.279 0.022
201712 -0.043 103.793 -0.049
201803 0.051 103.962 0.058
201806 0.410 104.875 0.463
201809 0.038 105.679 0.043
201812 -0.007 105.912 -0.008
201903 0.027 105.886 0.030
201906 -0.004 106.742 -0.004
201909 -0.001 107.214 -0.001
201912 -0.016 107.766 -0.018
202003 0.039 106.563 0.043
202006 0.012 107.498 0.013
202009 -0.001 107.635 -0.001
202012 -0.014 108.296 -0.015
202103 0.028 108.360 0.031
202106 -0.012 108.928 -0.013
202109 0.030 110.338 0.032
202112 -0.053 112.486 -0.056
202206 0.000 118.384 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Karo Pharma AB  (OTCPK:KARBF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Karo Pharma AB E10 Related Terms

Thank you for viewing the detailed overview of Karo Pharma AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Karo Pharma AB (Karo Pharma AB) Business Description

Traded in Other Exchanges
N/A
Address
Klara Norra Kyrkogata 33, Stockholm, SWE, 111 22
Karo Pharma AB is a healthcare corporation. It is engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of development and sale of products to pharmacies, digital distribution channels and food stores. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Karo Pharma AB (Karo Pharma AB) Headlines

From GuruFocus

Avista Capital Partners To Sell Trimb To Karo Pharma

By PRNewswire PRNewswire 06-25-2019